Company Description
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.
The company’s services include mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, MRT techniques, intracytoplasmic sperm injection, semen analysis, testicular sperm extraction/testicular sperm aspiration/PESA, egg freezing, and chromosome screening.
It also provides in vitro fertilization (IVF) treatment; surrogacy and ancillary caring services, including regular body check, as well as provision of vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.
The company offers its services through its clinics. The company was founded in 2010 and is based in Central, Hong Kong.
| Country | Hong Kong |
| Founded | 2011 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 70 |
| CEO | Wing Fung Siu |
Contact Details
Address: Pier 2, 1st Floor Central, 999077 Hong Kong | |
| Phone | 852 2869 1088 |
| Website | newgenivf.com |
Stock Details
| Ticker Symbol | NIVF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001981662 |
| ISIN Number | VGG0544E1051 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Wing Fung Siu | Co-Founder, Chairman and Chief Executive Officer |
| Hei Yue Fong | Co-Founder, Chief Marketing Officer and Director |
| Fai Chung Ho | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Apr 16, 2025 | 6-K | Report of foreign issuer |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 3, 2025 | 6-K | Report of foreign issuer |
| Mar 7, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 20, 2025 | 6-K | Report of foreign issuer |
| Feb 7, 2025 | 6-K/A | Filing |
| Jan 31, 2025 | 6-K | Report of foreign issuer |
| Jan 21, 2025 | 6-K | Report of foreign issuer |